SPIRIVA Side Effects

6939331-X | Benign Prostatic Hyperplasia, Urinary Incontinence
on Aug 11, 2010 Male patient from , 82 years of age, was diagnosed with lung neoplasm malignant, chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: benign prostatic hyperplasia, urinary incontinence (What is urinary incontinence?). Spiriva dosage: 18 Mcg. During the same period patient was treated with ASPIRIN (81 Mg) (View Aspirin Review and Aspirin Label ), LANOXIN (0.125 Mg) (View Lanoxin Review and Lanoxin Label ), ZOCOR (40 Mg) (View Zocor Review and Zocor Label ), LASIX (20 Mg) (View Lasix Review and Lasix Label ), DOXASIN (8 Mg) (View Doxasin Review and Doxasin Label ).

6939070-5 | Asthma, Atonic Seizures, Constipation, Neurogenic Bladder, Pneumonia, Urinary Tract Infection
Patient was taking Spiriva (View Usage). Patient had the following side effects: asthma (What is asthma?), atonic seizures, constipation (What is constipation?), neurogenic bladder, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?) on Aug 18, 2010 from Additional patient health information: Male patient , weighting 94.14 lb, was diagnosed with chronic obstructive pulmonary disease, gastrooesophageal reflux disease, atrial fibrillation (What is atrial fibrillation?), constipation (What is constipation?) and. Spiriva dosage: 18 Mcg. During the same period patient was treated with TERSIGAN (4df) (View Tersigan Review and Tersigan Label ), RABEPRAZOLE SODIUM (10 Mg) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), FUROSEMIDE (40 Mg) (View Furosemide Review and Furosemide Label ), DIGOSIN (0.25 Mg) (View Digosin Review and Digosin Label ), PREDONINE (5 Mg) (View Predonine Review and Predonine Label ), MUCOTRON (1500 Mg) (View Mucotron Review and Mucotron Label ), MAGMITT (990 Mg) (View Magmitt Review and Magmitt Label ), SELBEX (150 Mg) (View Selbex Review and Selbex Label ). Patient was hospitalized.

6939002-X | Chest Discomfort, Chest Pain
Adverse event was reported on Aug 18, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease, asthma (What is asthma?) and. Location: , 61 years of age, After Spiriva was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?). During the same period patient was treated with ATROVENT (80 Mcg) (View Atrovent Review and Atrovent Label ), ALBUTEROL SULFATE AUTOHALER (Prn) (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), SERETIDE (View Seretide Review and Seretide Label ).

6938571-3 | Asthenia, Back Pain, Dizziness, Dry Mouth, Dysphagia, Dyspnoea, Dysuria, Epistaxis
on Aug 17, 2010 Female patient from , weighting 147.9 lb, was diagnosed with chronic obstructive pulmonary disease, dyspnoea, menopause (What is menopause?), blood cholesterol increased, sinus disorder, flatulence and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, back pain (What is back pain?), dizziness (What is dizziness?), dry mouth, dysphagia, dyspnoea, dysuria, epistaxis. Spiriva dosage: 18 Mcg. During the same period patient was treated with PREMARIN (0.3 Mg) (View Premarin Review and Premarin Label ), SIMVASTATIN (40 Mg) (View Simvastatin Review and Simvastatin Label ), ALLEGRA (180 Mg) (View Allegra Review and Allegra Label ), OMEPRAZOLE (20 Mg) (View Omeprazole Review and Omeprazole Label ), SINGULAIR (10 Mg) (View Singulair Review and Singulair Label ), ATENOLOL (25 Mg) (View Atenolol Review and Atenolol Label ), PROAIR HFA (2 Puf) (View Proair Hfa Review and Proair Hfa Label ).


6936867-2 | Confusional State, Mental Impairment, Pseudomonas Infection
on Aug 09, 2010 Female patient from , 80 years of age, was treated with Spiriva (View Usage). Patient had the following side effects: confusional state, mental impairment, pseudomonas infection. Spiriva dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6936010-X | Asthenia, Back Pain, Dizziness, Dry Mouth, Dysphagia, Dyspnoea, Dysuria, Epistaxis
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: asthenia, back pain (What is back pain?), dizziness (What is dizziness?), dry mouth, dysphagia, dyspnoea, dysuria, epistaxis on Aug 17, 2010 from Additional patient health information: Female patient , weighting 147.9 lb, was diagnosed with chronic obstructive pulmonary disease, dyspnoea, menopause (What is menopause?), blood cholesterol increased, sinus disorder, flatulence and. Spiriva dosage: 18 Mcg. During the same period patient was treated with PREMARIN (0.3 Mg) (View Premarin Review and Premarin Label ), SIMVASTATIN (40 Mg) (View Simvastatin Review and Simvastatin Label ), ALLEGRA (180 Mg) (View Allegra Review and Allegra Label ), OMEPRAZOLE (20 Mg) (View Omeprazole Review and Omeprazole Label ), SINGULAIR (10 Mg) (View Singulair Review and Singulair Label ), ATENOLOL (25 Mg) (View Atenolol Review and Atenolol Label ), PROAIR HFA (2 Puf) (View Proair Hfa Review and Proair Hfa Label ).

6933396-7 |
Adverse event was reported on Aug 18, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease and. Location: , 73 years of age, .

6930080-0 | Constipation, Dry Mouth, Oedema, Urinary Retention
on Aug 12, 2010 Female patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: constipation (What is constipation?), dry mouth, oedema, urinary retention. Spiriva dosage: 18 Mcg.

6928749-7 | Brain Oedema, Laryngeal Oedema
on Aug 11, 2010 Male patient from , 76 years of age, was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: brain oedema, laryngeal oedema. Spiriva dosage: .

6928058-6 | Dyspnoea
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea on Aug 05, 2010 from Additional patient health information: Female patient , 81 years of age, was diagnosed with asthma (What is asthma?), gastrooesophageal reflux disease and. Spiriva dosage: 18 Mcg. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ).

6925080-0 | Prostatomegaly
Adverse event was reported on Aug 02, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease, panic disorder (What is panic disorder?), anxiety (What is anxiety?) and. Location: , 69 years of age, Patient had the following side effects: prostatomegaly. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6924872-1 | Conjunctivitis
on Aug 09, 2010 Female patient from , weighting 100.1 lb, was diagnosed with chronic obstructive pulmonary disease, bronchitis chronic, hypertension and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: conjunctivitis. Spiriva dosage: 5 Mcg. During the same period patient was treated with PROTECADIN (2 Df) (View Protecadin Review and Protecadin Label ), MUCODYNE (2 Df) (View Mucodyne Review and Mucodyne Label ), CLARITHROMYCIN (2 Df) (View Clarithromycin Review and Clarithromycin Label ), THEO DUR (1 Df) (View Theo-dur Review and Theo-dur Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), NORVASC (1 Df) (View Norvasc Review and Norvasc Label ).

6924292-X | Capsule Issue, Device Issue, Product Quality Issue
on Aug 11, 2010 Female patient from UNITED STATES , 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: capsule issue, device issue, product quality issue. Spiriva dosage: Inhale Contents Or Capsyle Once Daily.

6922750-5 | Brain Oedema, Laryngeal Oedema
Patient was taking Spiriva (View Usage). Patient had the following side effects: brain oedema, laryngeal oedema on Aug 11, 2010 from Additional patient health information: Male patient , 76 years of age, . Spiriva dosage: .

6922749-9 | Brain Oedema, Laryngeal Oedema
Adverse event was reported on Aug 11, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: ) . Location: , 76 years of age, After Spiriva was administered, patient had the following side effects: brain oedema, laryngeal oedema.

6922748-7 | Brain Oedema, Laryngeal Oedema
on Aug 11, 2010 Male patient from , 76 years of age, was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, laryngeal oedema. Spiriva dosage: .

6922747-5 | Brain Oedema, Laryngeal Oedema
on Aug 11, 2010 Male patient from , 76 years of age, was treated with Spiriva (View Usage). Patient had the following side effects: brain oedema, laryngeal oedema. Spiriva dosage: .

6921827-8 | Cardiac Failure Congestive, Fluid Retention, Gout, Hernia
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: cardiac failure congestive, fluid retention, gout (What is gout?), hernia (What is hernia?) on Aug 04, 2010 from Additional patient health information: Male patient , 79 years of age, was diagnosed with tachycardia, blood cholesterol increased and. Spiriva dosage: 18 Mcg. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6920729-0 | Neck Pain
Adverse event was reported on Jul 31, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with dyspnoea, hypothyroidism, type 2 diabetes mellitus, hypertension, prophylaxis and. Location: , 86 years of age, Patient experienced the following unwanted or unexpected effects: neck pain. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), GLIPIZIDE (20 Mg) (View Glipizide Review and Glipizide Label ), METOPROLOL TARTRATE (20 Mg) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), METFORMIN HCL (20 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), ZETIA (20 Mg) (View Zetia Review and Zetia Label ), FUROSEMIDE (20 Mg) (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (20 Mg) (View Potassium Chloride Review and Potassium Chloride Label ).

6919672-2 | Chronic Obstructive Pulmonary Disease, Dyspnoea
on Jul 29, 2010 Male patient from , 66 years of age, weighting 405.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, dyspnoea. Spiriva dosage: .

6919483-8 | Anaphylactic Shock
on Aug 09, 2010 Male patient from , weighting 131.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: anaphylactic shock. Spiriva dosage: 5 Mcg. During the same period patient was treated with LIPITOR (5 Mg) (View Lipitor Review and Lipitor Label ), SULTANOL (4 Puf) (View Sultanol Review and Sultanol Label ).

6919137-8 | Dry Mouth, Dyspnoea, Intervertebral Disc Protrusion, Musculoskeletal Pain
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, dyspnoea, intervertebral disc protrusion, musculoskeletal pain on Aug 03, 2010 from Additional patient health information: Female patient , 62 years of age, was diagnosed with chronic obstructive pulmonary disease, pain (What is pain?) and. Spiriva dosage: 18 Mcg. Patient was hospitalized.

6915978-1 | Cardiac Failure Congestive, Fluid Retention, Gout, Hernia
Adverse event was reported on Aug 04, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with tachycardia, blood cholesterol increased and. Location: , 79 years of age, Patient had the following side effects: cardiac failure congestive, fluid retention, gout (What is gout?), hernia (What is hernia?). During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6913905-4 | Bladder Disorder, Urinary Retention
on Aug 02, 2010 Female patient from , weighting 156.5 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: bladder disorder, urinary retention. Spiriva dosage: 1 Anz. Patient was hospitalized.

6913434-8 | Dyspnoea
on Aug 06, 2010 Male patient from , 76 years of age, was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Spiriva dosage: .

6913433-6 | Condition Aggravated, Impaired Work Ability
Patient was taking Spiriva (View Usage). Patient had the following side effects: condition aggravated, impaired work ability on Aug 03, 2010 from Additional patient health information: Female patient , weighting 300.0 lb, was diagnosed with dyspnoea, neuropathy peripheral, arthritis (What is arthritis?) and. Spiriva dosage: 36 Mcg. During the same period patient was treated with LYRICA (300 Mg) (View Lyrica Review and Lyrica Label ), CELEBREX (400 Mg) (View Celebrex Review and Celebrex Label ), LISINOPRIL (20 Mg) (View Lisinopril Review and Lisinopril Label ), VENTOLIN (2 Puf) (View Ventolin Review and Ventolin Label ), SIMVASTATIN (20 Mg) (View Simvastatin Review and Simvastatin Label ), METFORMIN HCL (2000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ), LASIX (80 Mg) (View Lasix Review and Lasix Label ).

6911745-3 | Anxiety, Arthralgia, Fatigue, Feeling Abnormal, Hypersomnia, Hypertension, Lethargy, Loss Of Consciousness, Malaise
Adverse event was reported on Jul 30, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: ) was diagnosed with nerve injury and. Location: , weighting 163.0 lb, After Spiriva was administered, patient had the following side effects: anxiety (What is anxiety?), arthralgia, fatigue, feeling abnormal, hypersomnia, hypertension, lethargy, loss of consciousness, malaise. During the same period patient was treated with CHANTIX (0.5 Mg) (View Chantix Review and Chantix Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), CLONAZEPAM (10 Mg) (View Clonazepam Review and Clonazepam Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ). Patient was hospitalized.

6910361-7 | Dyspnoea
on Jul 27, 2010 Female patient from , 74 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Spiriva dosage: 18 Mcg.

6910266-1 | Bladder Disorder, Urinary Retention
on Aug 02, 2010 Female patient from , weighting 156.5 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: bladder disorder, urinary retention. Spiriva dosage: 1 Anz. Patient was hospitalized.

6908103-4 | Cheilitis, Dyspnoea, Vision Blurred
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: cheilitis, dyspnoea, vision blurred on Aug 02, 2010 from Additional patient health information: Male patient , 76 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and. Spiriva dosage: 18 Mcg. During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ), ZBAR (View Zbar Review and Zbar Label ), SEREVENT (View Serevent Review and Serevent Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6907703-5 | Intentional Overdose, Suicidal Ideation
Adverse event was reported on Aug 03, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: ) was diagnosed with asthma (What is asthma?), fibromyalgia, neuropathy peripheral, pain (What is pain?), sleep disorder (What is sleep disorder?), anxiety (What is anxiety?), dyspnoea and. Location: , weighting 190.0 lb, Patient experienced the following unwanted or unexpected effects: intentional overdose, suicidal ideation. During the same period patient was treated with LYRICA (225 Mg) (View Lyrica Review and Lyrica Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), COMPRESSED OXYGEN (View Compressed Oxygen Review and Compressed Oxygen Label ), BACLOFEN (10 Mg) (View Baclofen Review and Baclofen Label ).

6905603-8 | Constipation, Dry Mouth, Oedema, Urinary Retention
on Jul 29, 2010 Female patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: constipation (What is constipation?), dry mouth, oedema, urinary retention. Spiriva dosage: 18 Mcg.

6900637-1 | Semen Discolouration
on Jul 20, 2010 Male patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease, prophylaxis, blood cholesterol increased, hypertension, fluid retention and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: semen discolouration. Spiriva dosage: 18 Mcg. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), COREG (View Coreg Review and Coreg Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).

6899814-8 | Dry Mouth, Dyspnoea, Intervertebral Disc Protrusion, Musculoskeletal Pain
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, dyspnoea, intervertebral disc protrusion, musculoskeletal pain on Jul 28, 2010 from Additional patient health information: Female patient , 62 years of age, was diagnosed with chronic obstructive pulmonary disease, pain (What is pain?) and. Spiriva dosage: 18 Mcg. Patient was hospitalized.

6895911-1 | Metastases To Central Nervous System, Metastases To Spine, Pulmonary Embolism
Adverse event was reported on Jul 28, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 1 Puf) was diagnosed with prophylaxis and. Location: , weighting 197.8 lb, Patient had the following side effects: metastases to central nervous system, metastases to spine, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with MS CONTIN (90 Mg) (View Ms Contin Review and Ms Contin Label ), REMERON (View Remeron Review and Remeron Label ), DILANTIN (View Dilantin Review and Dilantin Label ), KEPPRA (3000 Mg) (View Keppra Review and Keppra Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6895798-7 | Arthritis, Respiratory Disorder
on Jul 20, 2010 Female patient from , 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: arthritis (What is arthritis?), respiratory disorder. Spiriva dosage: 18 Mcg.

6894783-9 | Pneumonia, Respiratory Distress, Upper Respiratory Tract Infection
on Jul 30, 2010 Male patient from UNITED STATES , 65 years of age, weighting 160.0 lb, was diagnosed with dyspnoea, chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), respiratory distress, upper respiratory tract infection. Spiriva dosage: 18 Mcg 1/day. During the same period patient was treated with BUDESONIDE (.5 Mg/2 Ml) (View Budesonide Review and Budesonide Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MORPHINE (View Morphine Review and Morphine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6887222-5 | Cough, Dyspnoea, Lip Swelling, Nasal Congestion, Restless Legs Syndrome, Rhinorrhoea, Swollen Tongue, Tongue Discolouration
Patient was taking Spiriva (View Usage). Patient had the following side effects: cough, dyspnoea, lip swelling, nasal congestion, restless legs syndrome, rhinorrhoea, swollen tongue, tongue discolouration on Jul 16, 2010 from Additional patient health information: Female patient , 86 years of age, was diagnosed with chronic obstructive pulmonary disease, sinus disorder, hypertension, gastrooesophageal reflux disease, hypersensitivity, restless legs syndrome and. Spiriva dosage: 18 Mcg. During the same period patient was treated with FLONASE (View Flonase Review and Flonase Label ), ATACAND (View Atacand Review and Atacand Label ), PREVACID (View Prevacid Review and Prevacid Label ), ALLEGRA (View Allegra Review and Allegra Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6886959-1 | Chronic Obstructive Pulmonary Disease
Adverse event was reported on Jul 27, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease and. Location: , 80 years of age, weighting 150.0 lb, After Spiriva was administered, patient had the following side effects: chronic obstructive pulmonary disease.

6884104-X | Dyspnoea
on Jul 20, 2010 Female patient from , 44 years of age, was diagnosed with asthma (What is asthma?) and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Spiriva dosage: .

6883963-4 | Vision Blurred, Vitreous Floaters
on Jul 13, 2010 Female patient from , 75 years of age, was diagnosed with chronic obstructive pulmonary disease, gastrooesophageal reflux disease, thyroid disorder and was treated with Spiriva (View Usage). Patient had the following side effects: vision blurred, vitreous floaters. Spiriva dosage: 18 Mcg. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), ASPIRIN (325 Mg) (View Aspirin Review and Aspirin Label ), LEVOXYL (75 Mg) (View Levoxyl Review and Levoxyl Label ).

6883892-6 | Bladder Pain, Cough, Dysphonia, Eye Pain, Halo Vision, Hyperhidrosis, Oropharyngeal Pain, Sensation Of Foreign Body
Patient was taking Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: bladder pain, cough, dysphonia, eye pain, halo vision, hyperhidrosis, oropharyngeal pain, sensation of foreign body on Jul 14, 2010 from Additional patient health information: Female patient , 65 years of age, was diagnosed with chronic obstructive pulmonary disease and. Spiriva dosage: 1 Capsule Daily Prn. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6883600-9 | Anaphylactic Shock
Adverse event was reported on Jul 27, 2010 by a Male patient taking Spiriva (View Usage) (Dosage: 5 Mcg) was diagnosed with chronic obstructive pulmonary disease and. Location: , weighting 131.4 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic shock. During the same period patient was treated with LIPITOR (5 Mg) (View Lipitor Review and Lipitor Label ), SULTANOL (4 Puf) (View Sultanol Review and Sultanol Label ).

6882899-2 | Chest Discomfort, Headache
on Jul 12, 2010 Female patient from , 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient had the following side effects: chest discomfort, headache (What is headache?). Spiriva dosage: 18 Mcg.

6881980-1 | Pneumonia, Pruritus
on Jul 23, 2010 Female patient from , 66 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: pneumonia (What is pneumonia?), pruritus. Spiriva dosage: . During the same period patient was treated with FUROSEMIDE (80 Mg) (View Furosemide Review and Furosemide Label ), LIPITOR (20 Mg) (View Lipitor Review and Lipitor Label ), EZETROL (10 Mg) (View Ezetrol Review and Ezetrol Label ), COUMADIN (3.5 Mg) (View Coumadin Review and Coumadin Label ), EFFEXOR (37.5 Mg) (View Effexor Review and Effexor Label ). Patient was hospitalized.

6879868-5 | Fall, Hip Fracture, Hypersensitivity, Orthopedic Procedure, Pain, Pruritus, Urticaria, Walking Aid User, Weight Decreased
Patient was taking Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hip fracture, hypersensitivity, orthopedic procedure, pain (What is pain?), pruritus, urticaria, walking aid user, weight decreased on Jul 22, 2010 from Additional patient health information: Male patient , 70 years of age, weighting 160.1 lb, . Spiriva dosage: . During the same period patient was treated with HUMIRA (2.8571 Mg) (View Humira Review and Humira Label ), FIORINAL (View Fiorinal Review and Fiorinal Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), IRON (View Iron Review and Iron Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6879801-6 | Muscular Weakness, Tremor
Adverse event was reported on Jul 15, 2010 by a Female patient taking Spiriva (View Usage) (Dosage: 18 Mcg) was diagnosed with chronic obstructive pulmonary disease, osteoporosis (What is osteoporosis?), hypothyroidism, hot flush, abdominal discomfort, cardiac failure congestive, blood potassium decreased and. Location: , 83 years of age, Patient had the following side effects: muscular weakness, tremor. During the same period patient was treated with ADVAIR DISKUS 100/50 (4 Puf) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ACTONEL (5 Mg) (View Actonel Review and Actonel Label ), LEVOTHROID (75 Mcg) (View Levothroid Review and Levothroid Label ), PREMPRO (0.45/1.5) (View Prempro Review and Prempro Label ), PANTOPRAZOLE (40 Mg) (View Pantoprazole Review and Pantoprazole Label ), FUROSEMIDE (40 Mg) (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (10 Meq) (View Potassium Chloride Review and Potassium Chloride Label ).

6877983-3 | Blood Glucose Increased
on Jul 22, 2010 Male patient from , 38 years of age, was treated with Spiriva (View Usage). After Spiriva was administered, patient had the following side effects: blood glucose increased. Spiriva dosage: 18 Mcg. During the same period patient was treated with APO SALVENT CFC FREE (View Apo-salvent Cfc Free Review and Apo-salvent Cfc Free Label ), ASAPHEN E.C. (View Asaphen E.c. Review and Asaphen E.c. Label ), NOVOLIN GE NPH (View Novolin Ge Nph Review and Novolin Ge Nph Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), NOVO VENLAFAXINE XR (View Novo Venlafaxine Xr Review and Novo Venlafaxine Xr Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6875519-4 | Blood Pressure Inadequately Controlled, Dyspnoea
on Jul 22, 2010 Male patient from , 60 years of age, weighting 310.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Spiriva (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, dyspnoea. Spiriva dosage: 18 Mcg. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), BYSTOLIC (5 Mg) (View Bystolic Review and Bystolic Label ), FUROSEMIDE (80 Mg) (View Furosemide Review and Furosemide Label ), LISINOPRIL (10 Mg) (View Lisinopril Review and Lisinopril Label ), POTASSIUM CHLORIDE (20 Mg) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6866094-9 | Erection Increased, Feeling Hot, Nocturia
Patient was taking Spiriva (View Usage). Patient had the following side effects: erection increased, feeling hot, nocturia on Jul 15, 2010 from Additional patient health information: Male patient , 83 years of age, was diagnosed with chronic obstructive pulmonary disease and. Spiriva dosage: 18 Mcg. During the same period patient was treated with IPRATROPIUM BROMIDE/ALBUTEROL (View Ipratropium Bromide/albuterol Review and Ipratropium Bromide/albuterol Label ).